Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised contr... von Gallwitz, Baptist, Prof, Guzman, Juan, MD, Dotta, Francesco, MD, Guerci, Bruno, MD, Simó, Rafael, MD, Basson, Bruce R, MSc, Festa, Andreas, MD, Kiljański, Jacek, MD, Sapin, Hélène, MSc, Trautmann, Michael, MD, Schernthaner, Guntram, Prof

Volltext

Evaluating glucose‐lowering treatment in older people with diabetes: Lessons from the IMPERIUM trial von Sinclair, Alan J., Heller, Simon R., Pratley, Richard E., Duan, Ran, Heine, Robert J., Festa, Andreas, Kiljański, Jacek

Volltext

Time to Failure on Oral Glucose-Lowering Agents for Patients with Type 2 Diabetes: A Retrospective Cohort Study von Boye, Kristina S., Lage, Maureen J., Kiljański, Jacek

Volltext

Glycaemic outcomes of an Individualized treatMent aPproach for oldER vulnerable patIents: A randomized, controlled stUdy in type 2 diabetes Mellitus (IMPERIUM) von Heller, Simon R., Pratley, Richard E., Sinclair, Alan, Festa, Andreas, Kiljański, Jacek, Brusko, Cynthia S., Duan, Ran, Heine, Robert J.

Volltext

Use of Insulin Glargine 100 U/mL for the Treatment of Type 2 Diabetes Mellitus in East Asians: A Review von Hirose, Takahisa, Chen, Ching-Chu, Ahn, Kyu Jeung, Kiljański, Jacek

Volltext

Initiation and Gradual Intensification of Premixed Insulin Lispro Therapy Versus Basal ± Mealtime Insulin in Patients With Type 2 Diabetes Eating Light Breakfasts von GIUGLIANO, Dario, TRACZ, Mariusz, WILLE, Simone A, KILJANSKI, Jacek, SHAH, Sanjiv, CALLE-PASCUAL, Alfonso, MISTODIE, Cristina, DUARTE, Rui, SARI, Ramazan, WOO, Vincent, JILETCOVICI, Alina O, DEINHARD, Jürgen

Volltext

Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study von Simó, Rafael, Guerci, Bruno, Schernthaner, Guntram, Gallwitz, Baptist, Rosas-Guzmàn, Juan, Dotta, Francesco, Festa, Andreas, Zhou, Ming, Kiljański, Jacek

Volltext

Patient-reported outcomes among patients using exenatide twice daily or insulin in clinical practice in six European countries: the CHOICE prospective observational study von Reaney, Matthew, Mathieu, Chantal, Ostenson, Claes-Göran, Matthaei, Stephan, Krarup, Thure, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael, Guerci, Bruno

Volltext

727-P: Glycemic Effect of Tirzepatide by Duration of Diabetes von DE BLOCK, CHRISTOPHE, MATHIEU, CHANTAL, SAPIN, HELENE, KILJANSKI, JACEK I., PELESHOK, JENNIFER

Volltext

777-P: Early Weight Loss and Late Metabolic Outcomes in Tirzepatide-Treated Participants with Type 2 Diabetes von LINGVAY, ILDIKO, GIORGINO, FRANCESCO, VAN GAAL, LUC, LIU, MINZHI, RODRÍGUEZ, ÁNGEL, TORCELLO-GOMEZ, AMELIA, KILJANSKI, JACEK I.

Volltext

729-P: Relationship between Body Weight Change and Glycemic Control with Tirzepatide Treatment in People with Type 2 Diabetes von PEDERSEN, SUE, UMPIERREZ, GUILLERMO E., GIORGINO, FRANCESCO, RODRÍGUEZ, ÁNGEL, THIEU, VIVIAN, SAPIN, HELENE, LANDO, LAURA FERNANDEZ, KARANIKAS, CHRISANTHI A., KILJANSKI, JACEK I.

Volltext

Using Exenatide Twice Daily or Insulin in Clinical Practice: Results from CHOICE von Mathieu, Chantal, Östenson, Claes-Göran, Matthaei, Stephan, Reaney, Matthew, Krarup, Thure, Guerci, Bruno, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Theodorakis, Michael

Volltext

Resource use and costs of exenatide bid or insulin in clinical practice: the European CHOICE study von Kiiskinen, Urpo, Matthaei, Stephan, Reaney, Matthew, Mathieu, Chantal, Ostenson, Claes-Göran, Krarup, Thure, Theodorakis, Michael, Kiljański, Jacek, Salaun-Martin, Carole, Sapin, Hélène, Guerci, Bruno

Volltext

Glycaemic outcomes of an I ndividualized treat M ent a P proach for old ER vulnerable pat I ents: A randomized, controlled st U dy in type 2 diabetes M ellitus ( IMPERIUM ) von Heller, Simon R., Pratley, Richard E., Sinclair, Alan, Festa, Andreas, Kiljański, Jacek, Brusko, Cynthia S., Duan, Ran, Heine, Robert J.

Volltext

Reduced Glucose Variability With Glucose-Dependent Versus Glucose-Independent Therapies Despite Similar Glucose Control and Hypoglycemia Rates in a Randomized, Controlled Study of... von Pratley, Richard E., Rosenstock, Julio, Heller, Simon R., Sinclair, Alan, Heine, Robert J., Kiljański, Jacek, Brusko, Cynthia S., Duan, Ran, Festa, Andreas

Volltext

Association of G-174C Polymorphism of the Interleukin-6 Gene Promoter with Graves' Ophthalmopathy von Bednarczuk, Tomasz, Kury owicz, Alina, Hiromatsu, Yuji, Kilja ski, Jacek, Telichowska, Anna, Nauman, Janusz

Volltext

Efficacy and Safety of Prandial Premixed Therapy Using Insulin Lispro Mix 50/50 3 Times Daily Compared With Progressive Titration of Insulin Lispro Mix 75/25 or Biphasic Insulin As... von Farcasiu, Eugenia, MD, PhD, Ivanyi, Tibor, MD, Mozejko-Pastewka, Barbara, MD, Birkus, Zita, MD, Csog, Jozsef, MD, Kowalska, Irina, MD, PhD, Coetzer, Thomas Frederic, MD, Bulgurlu, Sami, MD, Schinzel, Birgit, MSc, Kiljanski, Jacek, MD, PhD

Volltext

743-P: Clinical Factors Associated with Insulin Regression When Adding Tirzepatide in Basal Insulin–Treated Type 2 Diabetes von Wysham, Carol H, Rosenstock, Julio, Tofe, Santiago, Thieu, Vivian, Kiljanski, Jacek I, Lee, Clare, Wang, Hui, Patel, Hiren

Volltext

757-P: Near-Normoglycemia and Insulin Regression Induced by Tirzepatide in Basal Insulin–Treated Type 2 Diabetes von Rosenstock, Julio, Tofe, Santiago, Wysham, Carol H, Thieu, Vivian, Kiljanski, Jacek I, Lee, Clare, Wang, Hui, Patel, Hiren

Volltext

Long-Term Effects of Adding Exenatide to a Regimen of Metformin and/or Sulfonylurea in Type 2 Diabetes: An Uncontrolled, Open-Label Trial in Hungary von Iványi, Tibor, MD, Fövényi, József, MD, PhD, Faludi, Péter, MD, Han, Jenny, MS, MacConell, Leigh, PhD, Wille, Simone, MA, Kiljanski, Jacek, MD, PhD

Volltext